These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 19321696)

  • 1. Good performance of immunoglobulin M assays in diagnosing genotype 3 hepatitis E virus infections.
    Legrand-Abravanel F; Thevenet I; Mansuy JM; Saune K; Vischi F; Peron JM; Kamar N; Rostaing L; Izopet J
    Clin Vaccine Immunol; 2009 May; 16(5):772-4. PubMed ID: 19321696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of serologic assays for diagnosing acute hepatitis E in national surveillance of a nonendemic area.
    Wu WC; Su CW; Yang JY; Lin SF; Chen JY; Wu JC
    J Med Virol; 2014 Apr; 86(4):720-8. PubMed ID: 24395716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic performance of selected commercial HEV IgM and IgG ELISAs for immunocompromised and immunocompetent patients.
    Pas SD; Streefkerk RH; Pronk M; de Man RA; Beersma MF; Osterhaus AD; van der Eijk AA
    J Clin Virol; 2013 Dec; 58(4):629-34. PubMed ID: 24210958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of a new rapid test for detecting anti-hepatitis E virus immunoglobulin M in immunocompetent and immunocompromised patients.
    Abravanel F; Lhomme S; Chapuy-Regaud S; Peron JM; Alric L; Rostaing L; Kamar N; Izopet J
    J Clin Virol; 2015 Sep; 70():101-104. PubMed ID: 26305830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of anti-HEV assays for diagnosing acute hepatitis E in immunocompromised patients.
    Abravanel F; Chapuy-Regaud S; Lhomme S; Miedougé M; Peron JM; Alric L; Rostaing L; Kamar N; Izopet J
    J Clin Virol; 2013 Dec; 58(4):624-8. PubMed ID: 24183927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic value of immunoglobulin G (IgG) and IgM anti-hepatitis E virus (HEV) tests based on HEV RNA in an area where hepatitis E is not endemic.
    Lin CC; Wu JC; Chang TT; Chang WY; Yu ML; Tam AW; Wang SC; Huang YH; Chang FY; Lee SD
    J Clin Microbiol; 2000 Nov; 38(11):3915-8. PubMed ID: 11060044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance characteristics of the VIDAS® ANTI-HEV IgM and IgG assays.
    Abravanel F; Goutagny N; Joffray R; Eichenlaub E; Baron S; Aversenq A; Bourg S; Mercier L; Larue Triolet A; Poirault D; Loubet M; Daniel S; Luciani F; Pothion C; Tourneur C; Dugua JM; Lhomme S; Izopet J
    J Clin Virol; 2019 Mar; 112():10-14. PubMed ID: 30658273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative sensitivity of commercial tests for hepatitis E genotype 3 virus antibody detection.
    Avellon A; Morago L; Garcia-Galera del Carmen M; Munoz M; Echevarría JM
    J Med Virol; 2015 Nov; 87(11):1934-9. PubMed ID: 25959136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring of Anti-Hepatitis E Virus Antibody Seroconversion in Asymptomatically Infected Blood Donors: Systematic Comparison of Nine Commercial Anti-HEV IgM and IgG Assays.
    Vollmer T; Diekmann J; Eberhardt M; Knabbe C; Dreier J
    Viruses; 2016 Aug; 8(8):. PubMed ID: 27556482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Test performance characteristics of Anti-HEV IgG assays strongly influence hepatitis E seroprevalence estimates.
    Wenzel JJ; Preiss J; Schemmerer M; Huber B; Jilg W
    J Infect Dis; 2013 Feb; 207(3):497-500. PubMed ID: 23148290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of serological assays for diagnosis of hepatitis E virus genotype 1 and 3 infections in a setting of low endemicity.
    Herremans M; Bakker J; Duizer E; Vennema H; Koopmans MP
    Clin Vaccine Immunol; 2007 May; 14(5):562-8. PubMed ID: 17360853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are VIDAS® anti-HEV IgM and IgG assays fit for reliable diagnosis of hepatitis E virus infections?
    Cattoir L; Vercauteren KOA; Padalko E; De Beenhouwer H; Van Vaerenbergh K; Boel A
    Acta Clin Belg; 2021 Feb; 76(1):25-31. PubMed ID: 31402757
    [No Abstract]   [Full Text] [Related]  

  • 13. Serological response to hepatitis E virus genotype 3 infection: IgG quantitation, avidity, and IgM response.
    Bendall R; Ellis V; Ijaz S; Thurairajah P; Dalton HR
    J Med Virol; 2008 Jan; 80(1):95-101. PubMed ID: 18041018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A preliminary study on hepatitis E virus antibody IgG and IgM for the diagnosis of acute hepatitis E].
    Li K; Zhuang H; Zhu W; Ruan B; Jiang J; Li S; Zhai Q; Yao Z; Tang R; Chen Y
    Zhonghua Nei Ke Za Zhi; 1999 Nov; 38(11):733-6. PubMed ID: 11798711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic Performance of Five Assays for Anti-Hepatitis E Virus IgG and IgM in a Large Cohort Study.
    Norder H; Karlsson M; Mellgren Å; Konar J; Sandberg E; Lasson A; Castedal M; Magnius L; Lagging M
    J Clin Microbiol; 2016 Mar; 54(3):549-55. PubMed ID: 26659210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance Evaluation of Different Commercial Serological Kits for Diagnosis of Acute Hepatitis E Viral Infection.
    Zhang Q; Zong X; Li D; Lin J; Li L
    Pol J Microbiol; 2020 Sep; 69(2):217-222. PubMed ID: 32548990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute infection by hepatitis E virus with a slight immunoglobulin M antibody response.
    Inagaki Y; Oshiro Y; Imanishi M; Ishige K; Takahashi M; Okamoto H; Ohkohchi N
    Clin J Gastroenterol; 2015 Aug; 8(4):247-52. PubMed ID: 26215116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance evaluation of five commercial assays in assessing seroprevalence of HEV antibodies among blood donors.
    Al-Absi ES; Al-Sadeq DW; Younis MH; Yassine HM; Abdalla OM; Mesleh AG; Hadwan TA; Amimo JO; Thalib L; Nasrallah GK
    J Med Microbiol; 2018 Sep; 67(9):1302-1309. PubMed ID: 30051802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous detection of immunoglobulin A (IgA) and IgM antibodies against hepatitis E virus (HEV) Is highly specific for diagnosis of acute HEV infection.
    Takahashi M; Kusakai S; Mizuo H; Suzuki K; Fujimura K; Masuko K; Sugai Y; Aikawa T; Nishizawa T; Okamoto H
    J Clin Microbiol; 2005 Jan; 43(1):49-56. PubMed ID: 15634950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative evaluation of two immunoassays for serological diagnosis of hepatitis E.
    Sampedro A; Casanovas I; Ceballos J; Rodriguez-Granger J; Cobo F; Navarro JM
    J Med Virol; 2020 Feb; 92(2):260-262. PubMed ID: 31579928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.